| PUBCHEM ID |
119025810
|
| UNII |
7F0U74Q9B1
|
| Preferred Term |
PEG-3 ALPHA-LINOLENAMIDE
|
| CAS |
|
| INCHIKEY |
FLBSWNJNJBRLPB-PDBXOOCHSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CC/C=C\C/C=C\C/C=C\CCCCCCCC(NCCOCCOCCO)=O
|
| Total Surface Area |
380,98
|
| Relative PSA |
0,15119
|
| TPSA |
67,79
|
| cLogS |
-3,722
|
| MW |
409,608
|
| cLogP |
5,463
|
| H-Acceptors |
5
|
| H-Donors |
2
|
| Ro5 violations |
1
|
| Druglikeness |
-34,022
|
| DrugScore |
0,129506900046055
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
low
|
| Irritant |
high
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,5167
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
Low FHMT
|
| Fish Toxicity II |
2,9949
|
| Tetrahymena Pyriformis Toxicity I |
Low TPT
|
| Tetrahymena Pyriformis Toxicity II |
-0,6824
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Ready biodegradable
|
| Acute Oral Toxicity |
IV
|
| Rat Acute Toxicity |
1,6219
|
| Carcinogenicity (Three-class) |
Non-required
|
